Lactulose

Revision as of 16:29, 4 June 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Lactulose
Clinical data
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
BioavailabilityPoorly absorbed
Metabolism100% in colon by enteric bacteria
Elimination half-life1.7-2 hours
ExcretionFaecal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H22O11
Molar mass342.296 g/mol

WikiDoc Resources for Lactulose

Articles

Most recent articles on Lactulose

Most cited articles on Lactulose

Review articles on Lactulose

Articles on Lactulose in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lactulose

Images of Lactulose

Photos of Lactulose

Podcasts & MP3s on Lactulose

Videos on Lactulose

Evidence Based Medicine

Cochrane Collaboration on Lactulose

Bandolier on Lactulose

TRIP on Lactulose

Clinical Trials

Ongoing Trials on Lactulose at Clinical Trials.gov

Trial results on Lactulose

Clinical Trials on Lactulose at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lactulose

NICE Guidance on Lactulose

NHS PRODIGY Guidance

FDA on Lactulose

CDC on Lactulose

Books

Books on Lactulose

News

Lactulose in the news

Be alerted to news on Lactulose

News trends on Lactulose

Commentary

Blogs on Lactulose

Definitions

Definitions of Lactulose

Patient Resources / Community

Patient resources on Lactulose

Discussion groups on Lactulose

Patient Handouts on Lactulose

Directions to Hospitals Treating Lactulose

Risk calculators and risk factors for Lactulose

Healthcare Provider Resources

Symptoms of Lactulose

Causes & Risk Factors for Lactulose

Diagnostic studies for Lactulose

Treatment of Lactulose

Continuing Medical Education (CME)

CME Programs on Lactulose

International

Lactulose en Espanol

Lactulose en Francais

Business

Lactulose in the Marketplace

Patents on Lactulose

Experimental / Informatics

List of terms related to Lactulose

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Lactulose is a synthetic sugar used in the treatment of constipation and hepatic encephalopathy, a complication of liver disease. It is a disaccharide (double-sugar) formed from one molecule each of the simple sugars (monosaccharides) fructose and galactose. The commercial syrup used for treatment of constipation is dyed yellow-orange. It is produced commercially by isomerization of lactose.

Constipation

In the treatment of chronic constipation, its metabolites draw water into the bowel, causing a cathartic effect through osmotic action.

It can be especially useful for negating the constipating effects of opiates and opioids.

It can be also useful for treating children that withhold their bowel movements out of fear.

Lactulose has an overly sweet taste that can be completely masked by mixing it with fruit juice or desserts. It can take 24 to 48 hours to work, but generally produces results within 4 hours if taken on a daily basis. It is best taken at breakfast along with a bowl of bran cereal.

Hepatic encephalopathy

In treating hepatic encephalopathy, lactulose helps "draw out" ammonia (NH3) from the body. The effectiveness of lactulose is somewhat controversial, and whether or not its effects are through ammonia is controversial as well. Lactulose is metabolized in the colon by bacterial flora to short chain fatty acids, acidifying the colonic contents. This favors the formation of the nonabsorbable NH4+ from NH3, trapping NH3 in the colon and effectively reducing plasma NH3 concentrations.

Side effects

Common side effects are abdominal cramping, gas, borborygmus and embarrassing flatulence. Less common side effects are nausea and vomiting. Excessively high dosage can cause explosive and uncontrollable diarrhea. In sensitive individuals, such as the elderly or people with reduced kidney function, excess dosage can result in dehydration and high sodium levels.

Brand names

  • Generlac®
  • Cephulac®
  • Cholac®
  • Constilac®
  • Enulose®
  • Acilac®
  • Heptalac®
  • Actilax®
  • Duphalac®
  • Kristalose®
  • Apo-Lactulose

References

  • Medline Plus
  • Deglin, J. H., & Vallerand A. H. (2003). Lactulose. In Davis's drug guide for nurses (9th ed.) (pp. 589-590). Philadelphia:F. A. Davis.
  • Actilax / Lactulose Virtual Cancer Centre

Template:SIB

Template:WH Template:WikiDoc Sources